Eutilex Co., Ltd.
http://www.eutilex.com/en/
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Eutilex Co., Ltd.
ViGenCell’s Immune Cell Therapies To Get A Boost From $85M IPO
Korean bioventure ViGenCell successfully completes an IPO on the Kosdaq market with strong subscription rates from investors, reflecting the continued keen interest in biopharma shares in South Korea this year.
High-Tech Solutions For Stroke Rehab
Clinicians who work with stroke patients are beginning to look at robotics and other innovative technologies in rehabilitation that could allow for more treatments without increasing staffing. Young companies with products in development compete with established players in this market, which eventually could become more important to providers as reform efforts move ahead.
Recent Financings of Private Companies (04/11)
Start-Up's monthly comprehensive review of emerging life science companies that have received venture funding during the month, including companies in the pharmaceutical, medical device, diagnostic and research instrumentation and reagent sectors.
Deals Update
A roundup of recent medtech strategic alliances, mergers & acquisitions and financings.
Company Information
- Industry
-
Pharmaceuticals
- Drug Delivery
-
Biotechnology
- Gene Therapy, Cell Therapy
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice